[go: up one dir, main page]

MX171025B - ORAL COMPOSITION TO INHIBIT THE HUMAN DENTAL PLATE - Google Patents

ORAL COMPOSITION TO INHIBIT THE HUMAN DENTAL PLATE

Info

Publication number
MX171025B
MX171025B MX203917A MX20391784A MX171025B MX 171025 B MX171025 B MX 171025B MX 203917 A MX203917 A MX 203917A MX 20391784 A MX20391784 A MX 20391784A MX 171025 B MX171025 B MX 171025B
Authority
MX
Mexico
Prior art keywords
oral composition
inhibit
human dental
dental plate
oral
Prior art date
Application number
MX203917A
Other languages
Spanish (es)
Inventor
Abdul Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX171025B publication Critical patent/MX171025B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

La presente invención se refiere a una composición oral para inhibir la placa dental humana tal como mediante inhibir la sujeción de la bacteria actinomyces viscosus a las superficies orales, caracterizada porque contiene un vehículo oral dentalmente aceptable y una cantidad efectiva inhibidora de placa de homopolímero de ácido fosfónico vinilo, el homopolímero teniendo un peso molecular de desde 6,000 a 10,700, o una sal oralmente aceptable de el mismo.The present invention relates to an oral composition for inhibiting human dental plaque such as by inhibiting the attachment of the actinomyces viscosus bacteria to oral surfaces, characterized in that it contains a dentally acceptable oral vehicle and an effective amount of acid homopolymer plaque inhibitor. phosphonic vinyl, the homopolymer having a molecular weight of from 6,000 to 10,700, or an orally acceptable salt thereof.

MX203917A 1983-12-28 1984-12-28 ORAL COMPOSITION TO INHIBIT THE HUMAN DENTAL PLATE MX171025B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56636783A 1983-12-28 1983-12-28

Publications (1)

Publication Number Publication Date
MX171025B true MX171025B (en) 1993-09-24

Family

ID=24262588

Family Applications (1)

Application Number Title Priority Date Filing Date
MX203917A MX171025B (en) 1983-12-28 1984-12-28 ORAL COMPOSITION TO INHIBIT THE HUMAN DENTAL PLATE

Country Status (24)

Country Link
JP (1) JPS60169423A (en)
KR (1) KR880002522B1 (en)
AT (1) ATA402284A (en)
AU (1) AU571919B2 (en)
BE (1) BE901404A (en)
CA (1) CA1260837A (en)
CH (1) CH661440A5 (en)
DE (1) DE3445695A1 (en)
DK (1) DK168060B1 (en)
ES (1) ES8800840A1 (en)
FI (1) FI84021C (en)
FR (1) FR2557454B1 (en)
GB (1) GB2151478B (en)
GR (1) GR82565B (en)
HK (1) HK100790A (en)
IT (1) IT1178324B (en)
MX (1) MX171025B (en)
NL (1) NL8403941A (en)
NO (1) NO845265L (en)
NZ (1) NZ210618A (en)
PH (1) PH24564A (en)
PT (1) PT79721A (en)
SE (1) SE502745C2 (en)
SG (1) SG82090G (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
GB2224204B (en) * 1988-10-25 1992-06-03 Colgate Palmolive Co Dental composition comprising polyvinyl phosphonic acid
SE507731C2 (en) * 1988-12-29 1998-07-06 Colgate Palmolive Co Antibacterial oral antiplaque composition
ES2023294A6 (en) * 1988-12-29 1992-01-01 Colgate Palmolive Co Oral compositions anti-plate packaged. (Machine-translation by Google Translate, not legally binding)
IL92693A0 (en) * 1989-08-25 1990-09-17 Colgate Palmolive Co Antibacterial antiplaque composition containing novel styrene-phosphonic acid copolymer
SE512333C2 (en) * 1989-08-25 2000-02-28 Colgate Palmolive Co Antibacterial oral composition with plaque- and tartar-limiting action
ZM5189A1 (en) * 1989-08-25 1990-07-27 Colgate Palmolive Co Antiplaque antibacterial oral composition
US5292501A (en) * 1990-06-25 1994-03-08 Degenhardt Charles R Use of a carboxy-substituted polymer to inhibit plaque formation without tooth staining
US5093170A (en) * 1990-06-25 1992-03-03 The Procter & Gamble Co. Use of a carboxy-substituted polymer to inhibit plaque formation without tooth staining
US5213789A (en) * 1990-08-02 1993-05-25 The Procter & Gamble Company Use of a carboxy-containing copolymer to inhibit plaque formation without tooth staining
BRPI0821858A2 (en) * 2008-02-08 2014-09-30 Colgate Palmolive Co COMPOSITION, ORAL CARE COMPOSITION, AND METHOD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1429963A (en) * 1920-03-01 1922-09-26 George W Nelson Foot-measuring device
US3429963A (en) * 1964-06-09 1969-02-25 Colgate Palmolive Co Dental preparation containing polymeric polyelectrolyte
ZA717486B (en) * 1970-11-19 1973-06-27 Colgate Palmolive Co Treatment of teeth
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US4342857A (en) * 1980-12-31 1982-08-03 Colgate-Palmolive Company Antigingivitis composition comprising vinyl phosphonic acid/vinyl phosphonyl fluoride copolymer

Also Published As

Publication number Publication date
NL8403941A (en) 1985-07-16
GB2151478B (en) 1987-12-16
GB8432506D0 (en) 1985-02-06
DE3445695A1 (en) 1985-07-11
SE8406431L (en) 1985-06-29
JPS60169423A (en) 1985-09-02
DK617984A (en) 1985-06-29
CH661440A5 (en) 1987-07-31
IT8449349A0 (en) 1984-12-24
IT1178324B (en) 1987-09-09
SE502745C2 (en) 1995-12-18
FI845120A0 (en) 1984-12-27
AU571919B2 (en) 1988-04-28
SG82090G (en) 1990-11-23
DK617984D0 (en) 1984-12-20
FI84021B (en) 1991-06-28
DK168060B1 (en) 1994-01-31
ATA402284A (en) 1988-11-15
BE901404A (en) 1985-06-28
KR880002522B1 (en) 1988-11-28
CA1260837A (en) 1989-09-26
PH24564A (en) 1990-08-03
ES8800840A1 (en) 1987-12-01
NZ210618A (en) 1988-05-30
HK100790A (en) 1990-12-07
FI84021C (en) 1991-10-10
SE8406431D0 (en) 1984-12-18
ES539087A0 (en) 1987-12-01
PT79721A (en) 1985-01-01
AU3717284A (en) 1985-07-04
NO845265L (en) 1985-07-01
FI845120L (en) 1985-06-29
FR2557454A1 (en) 1985-07-05
GR82565B (en) 1985-05-07
GB2151478A (en) 1985-07-24
FR2557454B1 (en) 1988-12-16

Similar Documents

Publication Publication Date Title
MX166594B (en) ANTISEPTIC COMPOSITIONS CONTAINING HEXAHYDRO-5-PYRIMIDINAMINE AND THYMOL COMPOUNDS AND METHODS FOR PREPARING THEM
ATE91233T1 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS AND THEIR USE.
DE59204623D1 (en) STORAGE-RESISTANT, PERMANENTLY WET-WETTABLE VULCANISATE RESULTING POLYSILOXANE.
ATE67085T1 (en) MEANS FOR ORAL HYGIENE.
MX171025B (en) ORAL COMPOSITION TO INHIBIT THE HUMAN DENTAL PLATE
MX9207169A (en) ORAL COMPOSITIONS TO SUPPRESS ORAL ODORS.
DE60228761D1 (en) PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND WITH IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) EFFECT AND ITS USE
ATE139445T1 (en) USE OF ZINC IONS TO TREAT PERIODONTITIS
DE3577851D1 (en) INOSITOL TRIPHOSPHATE, METHOD FOR THE PRODUCTION THEREOF AND THE PREPARATION CONTAINING IT.
ATE352282T1 (en) METHODS, COMPOSITIONS AND DENTAL ADMINISTRATION SYSTEMS FOR PROTECTING TOOTH SURFACES
DE69837324D1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY USING COPOLYMER-1
ES2120728T3 (en) PLATELET AGGREGATION INHIBITORS.
JPS5738708A (en) Composition for oral purpose
KR950702405A (en) ORAL COMPOSITIONS
RU94018524A (en) DERIVATIVES OF TETRAHYDROPYRANE, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
ES2110115T3 (en) PLATELET AGGREGATION INHIBITORS.
ES2180564T3 (en) 2-PHENYL-3-AZOILBENZOTIOFENOS TO INCREASE THROMBOMODULIN EXPRESSION.
CA2109435A1 (en) Compositions of N-(Phosphonoacetyl)-L-Aspartic Acid and Methods of Their Use as Broad Spectrum Antivirals
CA2444071A1 (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
DK0804418T3 (en) Platelet aggregation inhibitors
FR2315261A1 (en) ORAL COMPOSITIONS CONTAINING BIS-BIGUANIDES TO REDUCE DENTAL PLATE
ES433860A1 (en) 3-(4{40 -Alkoxy-benzoyl)-1,2,2-trimethylcyclopentane-carboxylic acids, methods of use and compositions containing such compounds
IT8022843A0 (en) ENDO-8-METHYL-8-SIN-ALKYL-8-AZONIABICICLO OPEN SALTS PAR. SQUARE 3.2.1.CLOSED PAR.QUADRATA-OCTAN-3-ALKYLCARBOXYLATES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
ES2052702T3 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PEPTIC ULCERS.
ATE126969T1 (en) CHEWING GUM MASS, METHOD FOR THE PRODUCTION AND USE THEREOF.